The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline disease characteristics of participants enrolled on ENZARAD (ANZUP1303) and DASL-HiCaP (ANZUP1801) trials of highly effective androgen receptor antagonists in high-risk localized or locally advanced prostate cancer (PCa).
 
Tamim Niazi
Stock and Other Ownership Interests - Knight Pharmaceuticals
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Merck; Sanofi; Tersera; Tolmar
Consulting or Advisory Role - Abbvie; AstraZeneca Canada; Bayer; Janssen Oncology; Sanofi; Tersera
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera
 
Paul L. Nguyen
Stock and Other Ownership Interests - Nanocan Therapeutics; Reversal Therapeutics; Stratagen Bio; Telerad Oncology; Volatilyx (I)
Consulting or Advisory Role - AIQ Solutions; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Myovant Sciences; Nanocan Therapeutics; Novartis; Theranano
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
 
Scott Williams
Consulting or Advisory Role - Amgen; Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Tilray (Inst)
 
Andrew James Martin
No Relationships to Disclose
 
Lisa Horvath
Employment - Connected Medical Solutions (I)
Leadership - ANZUP; Connected Medical Solutions (I)
Stock and Other Ownership Interests - Connected Medical Solutions (I); Imagion Biosystems
Honoraria - ANZUP; Astellas Pharma; Bayer; Janssen
Consulting or Advisory Role - Astellas Pharma; Bayer; Imagion Biosystems
Research Funding - Astellas Pharma
Patents, Royalties, Other Intellectual Property - Provisional patent Australian No. 2022902527 Prognostic Markers (plasma lipid prognostic signature in metastatic prostate cancer). Inventors: Horvath L, Meikle P, Scheinberg S, Lin HM, Sullivan D The patent is owned by the Chris O'Brien Lifehouse (my (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen-Cilag; MSD Oncology; Pfizer
 
Hayley Thomas
No Relationships to Disclose
 
Danka Sinikovic Zebic
Speakers' Bureau - Merck
 
Felicia Roncolato
No Relationships to Disclose
 
Tee Lim
No Relationships to Disclose
 
Chakiath Jose
No Relationships to Disclose
 
Jarad Martin
Employment - GenesisCare; SeeTreat
Stock and Other Ownership Interests - GenesisCare; Margin-Clear; SeeTreat
Honoraria - Abbvie
Consulting or Advisory Role - Ferring; Janssen Oncology; Sanofi
Research Funding - Ipsen (Inst); Mundipharma; Varian Medical Systems
 
Hans T. Chung
Honoraria - Tersera Canada Inc.; Tolmar Pharmaceuticals Canada Inc.
Travel, Accommodations, Expenses - Tolmar Pharmaceuticals Canada Inc.
 
Annie Ebacher
No Relationships to Disclose
 
Scott C. Morgan
Research Funding - Knight Therapeutics (Inst)
 
Simon Hughes
Honoraria - Astellas Pharma; Bayer
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
(OPTIONAL) Uncompensated Relationships - Accord Healthcare (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst)
 
Sean Matthew McBride
Consulting or Advisory Role - AstraZeneca; Janssen
Research Funding - AstraZeneca; Genentech
 
Paul J. Kelly
Honoraria - Boston Scientific
Consulting or Advisory Role - Genomic Health
Speakers' Bureau - Varian Medical Systems
 
Ian D. Davis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Ipsen (Inst); Janssen Oncology (Inst); Medivation (Inst); Movember Foundation (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Cadence Pharma; Genentech/Roche; Janssen Biotech; Lilly; Pfizer; POINT Biopharma; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon; Janssen Biotech (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination